Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study

References

• Navarese EP, Robinson JG, Kowalewski M, et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis [published correction appears in. JAMA. 2018;319(15):1566–1579. doi: 10.1001/jama.2018.2525.
   PubMed Web of Science ®Google Scholar
• Lee EY, Yang Y, Kim HS, et al. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention. Atherosclerosis. 2018;279:1–9. doi: 10.1016/j.atherosclerosis.2018.10.012.
   PubMed Web of Science ®Google Scholar
• Lu Q, Tian G, Zhang Y, et al. Low HDL-C predicts risk and PCI outcomes in the han Chinese population. Atherosclerosis. 2013;226(1):193–197. doi: 10.1016/j.atherosclerosis.2012.09.011.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Genest J, Boekholdt SM, et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet. 2010;376(9738):333–339. doi: 10.1016/S0140-6736(10)60713-1.
   PubMed Web of Science ®Google Scholar
• Kastelein JJ, van der Steeg WA, Holme I, et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008;117(23):3002–3009. doi: 10.1161/CIRCULATIONAHA.107.713438.
   PubMed Web of Science ®Google Scholar
• Hsia SH, Pan D, Berookim P, et al. A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease. Am J Cardiol. 2006;98(8):1047–1052. doi: 10.1016/j.amjcard.2006.05.024.
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007;298(7):776–785. doi: 10.1001/jama.298.7.776.
   PubMed Web of Science ®Google Scholar
• Yao HM, Wan YD, Zhang XJ, et al. Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI Centre. BMJ Open. 2014;4(8):e004892. doi: 10.1136/bmjopen-2014-004892.
   PubMed Web of Science ®Google Scholar
• Yao H, Wan Y, Zhang X, et al. Data from: long-term follow-up results in patients undergoing percutaneous coronary intervention (pci) with drug-eluting stents: results from a single high-volume pci center [dataset]. 2014 [cited 2023 Aug 11]. In: Dryad Digital Repository [Internet]. doi: 10.5061/dryad.13d31.
   Google Scholar
• Packard CJ, Ford I, Robertson M, et al. Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective study of pravastatin in the elderly at risk (PROSPER). Circulation. 2005;112(20):3058–3065. doi: 10.1161/CIRCULATIONAHA.104.526848.
   PubMed Web of Science ®Google Scholar
• Endo A, Yoshida Y, Kageshima K, et al. Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis. Intern Med. 2014;53(8):819–828. doi: 10.2169/internalmedicine.53.1438.
   PubMed Web of Science ®Google Scholar
• Yeh PS, Yang CM, Lin SH, et al. Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study. Atherosclerosis. 2013;228(2):472–477. doi: 10.1016/j.atherosclerosis.2013.03.015.
   PubMed Web of Science ®Google Scholar
• Schoenhagen P, Tuzcu EM, Apperson-Hansen C, et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the reversal of atherosclerosis with aggressive lipid lowering therapy (REVERSAL) trial. Circulation. 2006;113(24):2826–2834. doi: 10.1161/CIRCULATIONAHA.105.585703.
   PubMed Web of Science ®Google Scholar
• Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the asteroid trial. JAMA. 2006;295(13):1556–1565. doi: 10.1001/jama.295.13.jpc60002.
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Tuzcu EM, Sipahi I, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA. 2007;297(5):499–508. doi: 10.1001/jama.297.5.499.
   PubMed Web of Science ®Google Scholar
• Du R, Li M, Wang X, et al. LDL-C/HDL-C ratio associated with carotid intima-media thickness and carotid plaques in male but not female patients with type 2 diabetes. Clin Chim Acta. 2020;511:215–220. doi: 10.1016/j.cca.2020.10.014.
   PubMed Web of Science ®Google Scholar
• Wu Z, Li X, Wen Q, et al. Serum LDL-C/HDL-C ratio and the risk of carotid plaques: a longitudinal study. BMC Cardiovasc Disord. 2022;22(1):501. doi: 10.1186/s12872-022-02942-w.
   PubMed Web of Science ®Google Scholar
• Yokokawa H, Yasumura S, Tanno K, et al. Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a japanese Northern rural population. J Atheroscler Thromb. 2011;18(2):89–98. doi: 10.5551/jat.5215.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Hou J, Zhang Q, et al. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation. Lipids Health Dis. 2019;18(1):40. doi: 10.1186/s12944-019-0979-6.
   PubMedGoogle Scholar
• Liu L, Yin P, Lu C, et al. Association of LDL-C/HDL-C ratio with stroke outcomes within 1 year after onset: a Hospital-Based Follow-Up study. Front Neurol. 2020;11:408. doi: 10.3389/fneur.2020.00408.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Zaccardi F, Karppi J, et al. Is high serum LDL/HDL cholesterol ratio an emerging risk factor for sudden cardiac death? Findings from the KIHD study. J Atheroscler Thromb. 2017;24(6):600–608. doi: 10.5551/jat.37184.
   PubMed Web of Science ®Google Scholar
• Zheng J, Sun Z, Zhang X, et al. Non-traditional lipid profiles associated with ischemic stroke not hemorrhagic stroke in hypertensive patients: results from an 8.4 years follow-up study. Lipids Health Dis. 2019;18(1):9. doi: 10.1186/s12944-019-0958-y.
   PubMedGoogle Scholar
• Amarenco P, Goldstein LB, Callahan A, 3rd, et al. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Atherosclerosis. 2009;204(2):515–520. doi: 10.1016/j.atherosclerosis.2008.09.008.
   PubMed Web of Science ®Google Scholar
• You S, Zhong C, Xu J, et al. LDL-C/HDL-C ratio and risk of all-cause mortality in patients with intracerebral hemorrhage. Neurol Res. 2016;38(10):903–908. doi: 10.1080/01616412.2016.1204797.
   PubMed Web of Science ®Google Scholar
• Yu Y, Li M, Huang X, et al. A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study. Lipids Health Dis. 2020;19(1):238. doi: 10.1186/s12944-020-01413-5.
   PubMed Web of Science ®Google Scholar
• De Backer G, Jankowski P, Kotseva K, et al. Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 2019;285:135–146. doi: 10.1016/j.atherosclerosis.2019.03.014.
   PubMed Web of Science ®Google Scholar
• Bacquer D, Smedt D, Reiner Ž, et al. Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: real world evidence from clinical practice: data from the ESC-EORP EUROASPIRE V study. Eur J Prev Cardiol. 2020;27(15):1630–1636. doi: 10.1177/2047487319874898.
   PubMed Web of Science ®Google Scholar